Glucocorticoid Induced osteoporosis is the most common cause of secondary osteoporosis, most common iatrogenic cause of disease
- Previous and current exposure to glucocorticoids (GCs) increases the risk of fracture and bone loss
- The increase in fracture risk is not fully assessed by bone mineral density (BMD); is also related to alteration in bone quality and falls
- Prevention or treatment of osteoporosis should be considered in all patients who receive GCs
- Number guidelines for GIOP, which remains under-diagnosed and under-treated
- London Osteoporosis Clinic team are happy to help with management complex cases
If you are received steroid therapy for any medical condition, you should be assessed for the need to have to have treatment to protect your bones for the bone losing effects of the steroids.